Literature DB >> 20480490

Thiazolopyrimidine inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase (IspF) from Mycobacterium tuberculosis and Plasmodium falciparum.

Julie G Geist1, Susan Lauw, Victoria Illarionova, Boris Illarionov, Markus Fischer, Tobias Gräwert, Felix Rohdich, Wolfgang Eisenreich, Johannes Kaiser, Michael Groll, Christian Scheurer, Sergio Wittlin, José L Alonso-Gómez, W Bernd Schweizer, Adelbert Bacher, François Diederich.   

Abstract

A library of 40,000 compounds was screened for inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase (IspF) protein from Arabidopsis thaliana using a photometric assay. A thiazolopyrimidine derivative resulting from the high-throughput screen was found to inhibit the IspF proteins of Mycobacterium tuberculosis, Plasmodium falciparum, and A. thaliana with IC(50) values in the micromolar range. Synthetic efforts afforded derivatives that inhibit IspF protein from M. tuberculosis and P. falciparum with IC(50) values in the low micromolar range. Several compounds act as weak inhibitors in the P. falciparum red blood cell assay.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20480490     DOI: 10.1002/cmdc.201000083

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  15 in total

Review 1.  Biochemistry of the non-mevalonate isoprenoid pathway.

Authors:  Tobias Gräwert; Michael Groll; Felix Rohdich; Adelbert Bacher; Wolfgang Eisenreich
Journal:  Cell Mol Life Sci       Date:  2011-07-09       Impact factor: 9.261

2.  (Z)-4-Chloro-N-{3-[(4-chlorophenyl)sulfonyl]-2,3-dihydrobenzo[d]thiazol-2-ylidene}benzene-sulfonamide.

Authors:  Sydney M Watkins; Timothy J Hagen; Timothy S Perkins; Chong Zheng
Journal:  IUCrdata       Date:  2017-06-20

3.  Identification of novel small molecule inhibitors of 4-diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) kinase of Gram-negative bacteria.

Authors:  M Tang; S I Odejinmi; Y M Allette; H Vankayalapati; K Lai
Journal:  Bioorg Med Chem       Date:  2011-08-16       Impact factor: 3.641

4.  2C-Methyl-d-erythritol 4-phosphate enhances and sustains cyclodiphosphate synthase IspF activity.

Authors:  J Kipchirchir Bitok; Caren Freel Meyers
Journal:  ACS Chem Biol       Date:  2012-08-06       Impact factor: 5.100

5.  Synthesis and evaluation of stable substrate analogs as potential modulators of cyclodiphosphate synthase IspF.

Authors:  J Kipchirchir Bitok; Caren Freel Meyers
Journal:  Medchemcomm       Date:  2013-01       Impact factor: 3.597

6.  Crystal structures of IspF from Plasmodium falciparum and Burkholderia cenocepacia: comparisons inform antimicrobial drug target assessment.

Authors:  Patrick E F O'Rourke; Justyna Kalinowska-Tłuścik; Paul K Fyfe; Alice Dawson; William N Hunter
Journal:  BMC Struct Biol       Date:  2014-01-10

7.  p-TSA-promoted syntheses of 5H-benzo[h] thiazolo[2,3-b]quinazoline and indeno[1,2-d] thiazolo[3,2-a]pyrimidine analogs: molecular modeling and in vitro antitumor activity against hepatocellular carcinoma.

Authors:  Amit K Keshari; Ashok K Singh; Vinit Raj; Amit Rai; Prakruti Trivedi; Balaram Ghosh; Umesh Kumar; Atul Rawat; Dinesh Kumar; Sudipta Saha
Journal:  Drug Des Devel Ther       Date:  2017-05-29       Impact factor: 4.162

8.  Trafficked Proteins-Druggable in Plasmodium falciparum?

Authors:  Jasmin Lindner; Kamila Anna Meissner; Isolmar Schettert; Carsten Wrenger
Journal:  Int J Cell Biol       Date:  2013-04-28

9.  Structural and biophysical characterization of the Burkholderia pseudomallei IspF inhibitor L-tryptophan hydroxamate.

Authors:  Joy M Blain; Dakota L Grote; Sydney M Watkins; Gashaw M Goshu; Chanté Muller; James L Gorman; Gina Ranieri; Richard L Walter; Heike Hofstetter; James R Horn; Timothy J Hagen
Journal:  Bioorg Med Chem Lett       Date:  2021-07-21       Impact factor: 2.940

Review 10.  New Insight into Isoprenoids Biosynthesis Process and Future Prospects for Drug Designing in Plasmodium.

Authors:  Gagandeep S Saggu; Zarna R Pala; Shilpi Garg; Vishal Saxena
Journal:  Front Microbiol       Date:  2016-09-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.